Please login to the form below
reimbursement
This page shows the latest reimbursement news and features for those working in and with pharma, biotech and healthcare.
Janssen’s single tablet Symtuza gains NHS England funding
potential to support adherence to treatment, ”says Jennifer Lee, Director of Health Economics, Market Access and Reimbursement (HEMAR) and Advocacy at Janssen-Cilag Ltd.
Latest news
-
CHMP backs Spark’s Luxturna, but rejects Sarepta again
second – and according to Spark the “early … launch indicators have been very positive.”The European price will as ever depend on negotiations with member state reimbursement authorities.
-
Health secretary’s ‘rip off’ remarks anger UK pharma
Negotiations over the pricing and reimbursement for the drug have been going on for two years, with both sides claiming they have made exceptional offers.
-
Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock
Vertex has seen reimbursement for the drug rejected three times over a period of two and a half years, but now the two sides have reached an agreement.
-
Alnylam gets EU nod for Onpattro amid pricing backlash
ICER’s position on Onpattro doesn’t bode well for Alnylam’s chances of securing reimbursement for the product in EU countries, which are generally much more price-sensitive than the ... Ionis and Akcea secured EMA approval last month for their
-
NICE clears Ipsen’s Cabometyx in first-line kidney cancer
Hickling added: “This reimbursement decision reflects the importance of our partnership with NICE who recognise that there are still limited treatment options available for people who have advanced RCC, a cancer
More from news
Approximately 45 fully matching, plus 505 partially matching documents found.
Latest Intelligence
-
China: AstraZeneca’s new engine for growth and innovation
The central government has also updated its national reimbursement drug list (NRDL) to include more and more innovative treatments, although this list remains restricted and is not regularly updated. ... This means the out-of-pocket cost for healthcare
-
Stakeholder dialogue in Europe’s adaptive pathways pilot
Evidence suggests that medicines using the resulting accelerated access initiatives experience variable reimbursement outcomes due to uncertainties in the clinical or economic evidence base. ... In other words, what is satisfactory from a regulatory
-
‘Flexible working’: fashionable buzzword or fundamental business operation?
Externally, there are the usual issues: downward pressure on hourly rates, reduced client budgets, environmental pressures on new drug development and licensing/reimbursement.
-
Made in China
Even if a drug fails to make it on the national drug reimbursement list, there are formularies in the country’s cities and provinces that cover many millions of people.
-
The European Medicines Agency: PRIME’d for access?
That may mean that getting marketing authorisation, even if it happens more quickly, won’t necessarily translate into speedy access to reimbursement.
More from intelligence
Approximately 12 fully matching, plus 126 partially matching documents found.
Latest appointments
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
There he oversaw the oncology-focused company's launch in the region, as well as the launch and UK reimbursement of its PARP inhibitor in recurrent ovarian cancer. ... During her 16-year stint with Amgen, Hamill worked in a number of executive roles,
-
Weekly industry appointments
Brian Jamieson, chairman, Mesoblast, said: “Swedish’s strong understanding of US healthcare resource allocation and reimbursement metrics is in line with the board’s objective to strengthen its commercial focus.”.
-
Claes Buxfeldt joins NDA
Claes Buxfeldt joins NDA. He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board.
-
Mereo BioPharma appoints head of patient access and commercial planning
In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.
-
W2O bolsters its commercialisation offering
with pricing and reimbursement strategy and communications.
More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
The gene therapy revolution
burden of gaining reimbursement was a major hurdle for potential prescribers.
-
PRMA Consulting Ltd
Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy. ... Global reimbursement Director, top-20
-
Mastering the precision medicine opportunity
However, outside the US is a different story, where the reimbursement landscape for testing is heterogeneous and internal pathology capabilities are often preferred. ... Market reimbursement is driving the industry towards value-based care, which rewards
-
Medicines personalised for Tom, Dick and Harry
the diminished returns from small patient populations, with the gamble that reimbursement will be sanctioned due to reduced concerns of budget impact? ... In such cases, perhaps patent protection should be extended to permit adequate reimbursement to
-
Global Corporate Divestment Study
Expiring patents along with regulatory and reimbursement changes were significant divestment drivers.
More from PMHub
Approximately 0 fully matching, plus 56 partially matching documents found.
Featured jobs
-
Account Director
-
Negotiable
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Director – Global Healthcare PR
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Scientific Team Lead
-
Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Salary TBC
- Account Manager, Healthcare Advertising
-
Salary TBC
-
Account Director - Digital
-
Great salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
Subscribe to our email news alerts
- AcelRX’s potent opioid tablets set to win FDA backing for pain relief
- New leader at Medivir after setbacks
- Roche preps new Kadcyla filings after phase 3 trial win
- Porterhouse Medical Group boosts its scientific services team with two new appointments
- Redefining communications excellence
- AstraZeneca: building a new ‘open innovation’ pharma company
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- Redefining communications excellence
- How to be heard in today’s multichannel, multistakeholder, multimedia world...
- AstraZeneca: building a new ‘open innovation’ pharma company
- The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
- In conversation with Pfizer’s Erik Nordkamp
- Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...
Quick links
Infographics
